RxDoctor Payments Data

Priya Samant, DPM

Podiatrist · Las Vegas, NVNPI 1770997405

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for podiatrist clinicians in NV, where the typical reported total is $833.

$671in general payments, 2019–2025

Across 21 payments — averaging $31.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$121
  • Smith+Nephew$113
  • Bioventus LLC$82
  • Arthrosurface Incorporated$78
  • Johnson & Johnson$71
  • Stryker$56
  • plus $149 from 8 others

What the payments were for

  • Food & beverage$671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$671 in reported general payments places this provider in the 45th percentile of 44 podiatrist providers in Nevada.

See all podiatrist providers in Nevada

Medicare billing

Part B allowed, 2024
$76,006
Medicare patients
367
Services billed
1,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox22$371
Terbinafine Hcl18$147

Paid to pharmacies, not to this prescriber.

Other podiatrist in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →